Carol Moore: Daily

London's Espresso Translations earns elite dual certification, setting a new benchmark for trust in official legal, business, and immigration translations.

With 8x sales growth and 90% prediction accuracy, AI pioneer QuantHealth is proving that simulating clinical trials can slash pharma's $50B failure rate.

As Capricor prepares its Q4 earnings call, all eyes are on its DMD drug Deramiocel's FDA path, financial health, and next-gen exosome technology.

Eli Lilly and the WHO Foundation have launched a new collaboration to strengthen health systems and combat the escalating obesity crisis in underserved regions.

The parent of GOL and Avianca is adding seven A330-900s, signaling a major strategic push to challenge rivals in the lucrative long-haul market.

AIRO Group will present its future vision at a major tech conference, facing investor scrutiny amid ambitious growth plans and recent financial hurdles.

Genesis Land Development saw record revenues in 2025, but a drop in new orders and a cautious outlook reveal a strategy for a cooling Calgary market.

A new survey finds AI makes procurement teams 3.7x more resilient, yet many leaders are held back by a dangerous overconfidence in their own knowledge.

A family-owned firm's push for eco-friendly practices and triple ISO certification is reshaping Sydney's competitive commercial cleaning industry.

First images from EarthDaily's new satellite, powered by ABB's advanced optics, promise to transform global business and environmental monitoring.

With 86% of its employees calling it a great place to work, Maxim Healthcare's new certification reveals a strategy to combat burnout and win talent.

TAG's 2026 certifications highlight a global push for ad transparency as AI-driven fraud escalates, with leaders achieving a new standard of integrity.

Safepoint MGA partners with Solstice Innovations, adopting the Equinox™ platform to navigate complex NFIP rules and enhance service in coastal markets.

After a chaotic 2025, businesses face a new normal of complex digital taxes and aggressive enforcement, with only minor glimmers of relief in 2026.

With a NASDAQ bell ringing set, SuRo Capital's upcoming earnings will test if its big bets on private AI firms have paid off for public investors.

A novel drug delivery system could revolutionize Alzheimer's treatment, and Acumen Pharmaceuticals is leading the charge with its targeted therapy.

The deal sees CPM and MW Components move to UK-based Rosebank Industries, marking a major exit for the private equity firm and a strategic US expansion.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

The low-sugar candy pioneer lands a nationwide Costco deal, signaling a major shift in how Americans satisfy their sweet tooth and challenging market titans.

As hearing loss surges globally, Amplifon launches a worldwide campaign of free tests and awareness, blending public health with strategic market leadership.